B-12 (10mg)

Vitamin B-12 (Methylcobalamin) is an active form of cobalamin essential for neurological function and red blood cell formation, supplied as a sterile-filtered solution formulated and packaged in the USA. Each batch is verified for concentration and purity by HPLC, with independent third-party testing confirming quality standards above 99%. For laboratory research use only.

Laboratory teams rely on B-12 (10mg) for consistent preparation of peptide solutions in experimental protocols.

Each batch of B-12 (10mg) is checked for specification compliance to support dependable research workflows.

B-12 (10mg) is supplied as a laboratory accessory for peptide reconstitution, storage, and handling research workflows.

Each vial contains lyophilized peptide at the labeled quantity, and wholesale orders are packed in boxes of ten vials at a single per-vial price.

Quality assurance: every batch is purified by reversed-phase high-performance liquid chromatography and identity-confirmed by mass spectrometry, with purity above 99%. Lot-specific certificates of analysis are available on request. Store lyophilized vials at -20°C, protected from light and moisture; reconstitute with bacteriostatic water immediately before use and avoid repeated freeze-thaw cycles. For in-vitro laboratory research use only — not for human or veterinary use.

Research & Literature

The following peer-reviewed studies and reference documents are commonly consulted by researchers working with B-12 (10mg). Summaries are provided for orientation only and reflect the cited sources.

Methylcobalamin: A Potential Vitamin of Pain Killer^[1] — This review examined the analgesic and neuroprotective actions of methylcobalamin, a form of vitamin B12. It discussed evidence that methylcobalamin may relieve neuropathic pain and support peripheral nerve repair. The authors positioned methylcobalamin as a potentially useful adjunct in pain management beyond its classical role in treating vitamin B12 deficiency. (Neural Plasticity 2013)

Meta-analysis of methylcobalamin alone and in combination with lipoic acid in patients with diabetic peripheral neuropathy^[2] — This meta-analysis pooled clinical trials evaluating methylcobalamin, given alone or in combination with lipoic acid, in patients with diabetic peripheral neuropathy. The analysis reported that methylcobalamin-based regimens improved neuropathic symptoms and measures of nerve function. These results support methylcobalamin as a treatment option for diabetic peripheral neuropathy. (Diabetes Research and Clinical Practice 2013)

Mecobalamin^[3] — This drug profile reviewed the pharmacology and clinical evidence of mecobalamin (methylcobalamin) for peripheral neuropathy. It summarized the compound's mechanism of action, safety profile, and findings from clinical studies. The authors discussed the potential role of mecobalamin in treating neuropathic conditions and highlighted areas requiring further research. (Expert Opinion on Investigational Drugs 2008)

References

1. Zhang M, Han W, Hu S, Xu H. "Methylcobalamin: A Potential Vitamin of Pain Killer." Neural Plasticity. 2013. pubmed.ncbi.nlm.nih.gov/24455309/
2. Xu Q, Pan J, Yu J, Liu X, Liu L, Zuo X, Chen H, Wu H, Wang X. "Meta-analysis of methylcobalamin alone and in combination with lipoic acid in patients with diabetic peripheral neuropathy." Diabetes Research and Clinical Practice. 2013. doi.org/10.1016/j.diabres.2013.03.033
3. Zhang YF, Ning G. "Mecobalamin." Expert Opinion on Investigational Drugs. 2008. pubmed.ncbi.nlm.nih.gov/18491996/

All products are supplied as lyophilized powder for in-vitro laboratory research use only and are not for human or veterinary use.